ATE219928T1 - Verwendung von angiogenese-suppressoren zur hemmung des haarwuchses - Google Patents

Verwendung von angiogenese-suppressoren zur hemmung des haarwuchses

Info

Publication number
ATE219928T1
ATE219928T1 AT96909552T AT96909552T ATE219928T1 AT E219928 T1 ATE219928 T1 AT E219928T1 AT 96909552 T AT96909552 T AT 96909552T AT 96909552 T AT96909552 T AT 96909552T AT E219928 T1 ATE219928 T1 AT E219928T1
Authority
AT
Austria
Prior art keywords
hair growth
inhibit hair
angiogenesis suppressors
suppressors
angiogenesis
Prior art date
Application number
AT96909552T
Other languages
English (en)
Inventor
Gurpreet S Ahluwalia
Peter Styczynski
Douglas Shander
Original Assignee
Gillette Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gillette Co filed Critical Gillette Co
Application granted granted Critical
Publication of ATE219928T1 publication Critical patent/ATE219928T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A61K8/492—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A61Q7/02—Preparations for inhibiting or slowing hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/51—Chelating agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Furan Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrane Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)
AT96909552T 1995-02-28 1996-02-27 Verwendung von angiogenese-suppressoren zur hemmung des haarwuchses ATE219928T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39644695A 1995-02-28 1995-02-28
PCT/US1996/002790 WO1996026712A2 (en) 1995-02-28 1996-02-27 Use of angiogenesis suppressors for inhibiting hair growth

Publications (1)

Publication Number Publication Date
ATE219928T1 true ATE219928T1 (de) 2002-07-15

Family

ID=23567227

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96909552T ATE219928T1 (de) 1995-02-28 1996-02-27 Verwendung von angiogenese-suppressoren zur hemmung des haarwuchses

Country Status (12)

Country Link
US (1) US6093748A (de)
EP (1) EP0812185B1 (de)
JP (1) JP4063868B2 (de)
AR (1) AR003411A1 (de)
AT (1) ATE219928T1 (de)
AU (1) AU719106B2 (de)
BR (1) BR9607060A (de)
CA (1) CA2213404C (de)
DE (1) DE69622154T2 (de)
ES (1) ES2175084T3 (de)
WO (1) WO1996026712A2 (de)
ZA (1) ZA961600B (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5908867A (en) * 1996-07-18 1999-06-01 Henry; James P. Reduction of hair growth
FR2753375B1 (fr) * 1996-09-17 1999-12-03 Oreal Utilisation dans une composition cosmetique ou pour la preparation d'un medicament d'au moins un inhibiteur de sulfotransferases
JP3973748B2 (ja) 1998-01-14 2007-09-12 花王株式会社 発毛抑制剤
US5958946A (en) * 1998-01-20 1999-09-28 Styczynski; Peter Modulation of hair growth
JPH11279040A (ja) * 1998-03-27 1999-10-12 Kao Corp 皮膚外用剤
US6020006A (en) * 1998-10-27 2000-02-01 The Gillette Company Reduction of hair growth
WO2001028509A1 (en) * 1999-10-21 2001-04-26 Kao Corporation Depilatories and agents for external use
FR2805744B1 (fr) * 2000-03-03 2006-08-25 Sederma Sa Compositions cosmetiques ou dermopharmaceutiques contenant le dipeptide val-trp pour faciliter le drainage lymphatique et diminuer la masse adipeuse
US6299865B1 (en) 2000-05-02 2001-10-09 Peter Styczynski Reduction of hair growth
FR2812192B1 (fr) * 2000-07-28 2003-01-31 Oreal Utilisation d'antagonistes de recepteur des prostaglandines ep-3 comme agent cosmetique permettant d'attenuer, de diminuer ou d'arreter la chute des cheveux et des poils
FR2812190B1 (fr) * 2000-07-28 2003-01-31 Oreal Utilisation d'agonistes non prostanoiques des recepteurs des prostaglandines ep-2 et/ou ep-4 comme agent cosmetique permettant d'attenuer, de diminuer ou d'arreter la chute des cheveux et des poils
FR2812193B1 (fr) * 2000-07-28 2003-10-24 Oreal Utilisation d'antagoniste des recepteurs des prostaglandines ep-2 et/ou ep-4 pour attenuer, diminuer ou stopper la pousse des cheveux et des poils dans des preparations cosmetiques
FR2812191B1 (fr) * 2000-07-28 2003-10-17 Oreal Utilisation d'agonistes du recepteur des prostaglandines e2 (ep-3) pour attenuer, diminuer ou stopper la pousse des cheveux et des poils dans des preparations cosmetiques
WO2002089802A2 (en) * 2001-05-08 2002-11-14 Schering Corporation Use of neurokinin receptor antagonists to treat androgen-dependent diseases
US7439271B2 (en) 2001-06-27 2008-10-21 The Gillette Company Reduction of hair growth
ITPD20010187A1 (it) * 2001-07-23 2003-01-23 Cutech Srl Trattamento del follicolo polifero, in particolare contro la caduta dei capelli
JP4759182B2 (ja) * 2001-08-03 2011-08-31 花王株式会社 水溶性ショウキョウエキス
US7261878B2 (en) * 2001-08-10 2007-08-28 The Gillette Company Reduction of hair growth
US6743822B2 (en) 2001-08-10 2004-06-01 The Gillette Company Reduction of hair growth
US20030036561A1 (en) * 2001-08-10 2003-02-20 Peter Styczynski Reduction of hair growth
JP2005508358A (ja) * 2001-10-25 2005-03-31 デポメド・インコーポレイテッド 胃滞留型ロサルタン投与量を用いる治療方法
US6803382B2 (en) 2001-11-09 2004-10-12 Galderma Research & Development, S.N.C. Angiogenesis inhibitors and pharmaceutical and cosmetic use thereof
FR2832149B1 (fr) * 2001-11-09 2006-01-06 Galderma Res & Dev Nouveaux inhibiteurs de l'angiogenese et leur utilisation pharmaceutique et cosmetique
US7160921B2 (en) * 2002-01-29 2007-01-09 The Gillette Company Reduction of hair growth
US20040198821A1 (en) * 2002-01-29 2004-10-07 Hwang Cheng Shine Reduction of hair growth
US20030199584A1 (en) * 2002-04-11 2003-10-23 Ahluwalia Gurpreet S. Reduction of hair growth
US20040141935A1 (en) * 2003-01-21 2004-07-22 Peter Styczynski Reduction of hair growth
US7015349B2 (en) * 2003-03-26 2006-03-21 The Gillette Company Reduction of hair growth
US20050112075A1 (en) * 2003-11-25 2005-05-26 Hwang Cheng S. Reduction of hair growth
AU2005204685B2 (en) * 2004-01-07 2007-06-21 E-L Management Corporation Cosmetic composition and method for retarding hair growth
US7722901B2 (en) 2004-01-16 2010-05-25 Cognis Ip Management Gmbh Uses for the extract of a plant of the family Asclepiadaceae
US7223562B2 (en) * 2004-03-31 2007-05-29 New York University Compositions for controlling hair growth
US20050249685A1 (en) * 2004-04-27 2005-11-10 Natalia Botchkareva Reduction of hair growth
BRPI0519218A2 (pt) * 2004-12-22 2009-01-06 Gillette Co reduÇço do crescimento de cabelos ou pÊlos
WO2006069259A2 (en) * 2004-12-22 2006-06-29 The Gillette Company Reduction of hair growth
CN101087583A (zh) * 2004-12-22 2007-12-12 吉莱特公司 用生存素抑制剂来减少毛发生长
US7618956B2 (en) * 2005-05-31 2009-11-17 The Gillette Company Reduction of hair growth
US20070059264A1 (en) * 2005-09-13 2007-03-15 Ahluwalia Gurpreet S Reduction of hair growth
US7727516B2 (en) * 2006-02-28 2010-06-01 The Procter & Gamble Company Reduction of hair growth
AU2013201604B2 (en) * 2007-04-13 2014-08-14 Southern Research Institute Anti-angiogenic agents and methods of use
NZ608343A (en) * 2007-04-13 2014-09-26 Southern Res Inst Anti-angiogenic agents and methods of use
US7803902B2 (en) * 2008-10-15 2010-09-28 Danisco Us Inc. Modified variant bowman birk protease inhibitors
US7772181B2 (en) * 2008-10-15 2010-08-10 Danisco Us Inc. Personal care compositions comprising modified variant Bowman Birk Protease Inhibitors
US9676845B2 (en) 2009-06-16 2017-06-13 Hoffmann-La Roche, Inc. Bispecific antigen binding proteins
EP2753250B1 (de) 2011-09-10 2019-03-20 Cook Medical Technologies LLC Bedienungshandgriff für medizinische vorrichtungen
EP2581080A1 (de) * 2011-10-13 2013-04-17 Helmholtz-Zentrum für Infektionsforschung GmbH Inhibitor der Kolonisation der Schleimhaut
US10349958B2 (en) 2012-03-27 2019-07-16 Cook Medical Technologies Llc Lithotripsy probes and methods for performing lithotripsy
CN103479627A (zh) * 2013-05-16 2014-01-01 武汉光谷百桥国际生物科技有限公司 一种血管紧张素ii的i型受体拮抗剂在促进毛发生长方面的应用
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists
JPWO2022114111A1 (de) * 2020-11-27 2022-06-02

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3426137A (en) * 1965-12-23 1969-02-04 Olin Mathieson Hair growth inhibiting by aminobenzophenones
US4161540A (en) * 1966-08-22 1979-07-17 Schering Corporation Antiandrogenic agents and methods for the treatment of androgen dependent disease states
GB1458349A (en) * 1972-12-05 1976-12-15 Sykora F Composition for and a process therewith of treating the hair and/or scalps of animals
US4039669A (en) * 1975-08-01 1977-08-02 Sterling Drug Inc. Composition for topical application and use thereof
US4139638A (en) * 1976-09-23 1979-02-13 Schering Corporation Methods for the treatment of hirsutism
FR2380775A1 (fr) * 1977-02-22 1978-09-15 Sederma Sarl Composition " apres-epilation " favorisant un ralentissement progressif de la repousse des poils
US4191775A (en) * 1977-12-15 1980-03-04 Imperial Chemical Industries Limited Amide derivatives
US4269831A (en) * 1979-05-09 1981-05-26 Sterling Drug Inc. Topical dermatological method of use of an androstenopyrazole
DE2943776A1 (de) * 1979-10-26 1981-05-14 Schering Ag Berlin Und Bergkamen, 1000 Berlin 17 (alpha) -alkylsteroide, diese enthaltende praeparate sowie verfahren zu ihrer herstellung
US4439432A (en) * 1982-03-22 1984-03-27 Peat Raymond F Treatment of progesterone deficiency and related conditions with a stable composition of progesterone and tocopherols
US4885289A (en) * 1983-12-12 1989-12-05 Breuer Miklos M Alteration of character of male beard growth
US4720489A (en) * 1984-10-15 1988-01-19 Douglas Shander Hair growth modification with ornithine decarboxylase inhibitors
US5091171B2 (en) * 1986-12-23 1997-07-15 Tristrata Inc Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
WO1990012577A2 (en) * 1989-04-18 1990-11-01 The Upjohn Company Topical anti-angiogenic as hair growth inhibitors
US5096911A (en) * 1990-06-25 1992-03-17 Ahluwalia Gurpreet S Alteration of rate and character of hair growth
DE69128034T2 (de) * 1990-08-14 1998-04-16 Handelman Joseph H Enzymatische änderung des haarwuchses
US5189212A (en) * 1990-09-07 1993-02-23 University Of Georgia Research Foundation, Inc. Triarylethylene carboxylic acids with estrogenic activity
US5095007A (en) * 1990-10-24 1992-03-10 Ahluwalia Gurpreet S Alteration of rate and character of hair growth
DE4038693A1 (de) * 1990-12-05 1992-06-11 Heverhagen Ulrich Mittel zum reduzieren des wachstums bzw. zum entfernen der haare am menschlichen koerper
US5143925A (en) * 1990-12-20 1992-09-01 Douglas Shander Alteration of rate and character of hair growth
GB9118866D0 (en) * 1991-09-04 1991-10-23 Unilever Plc Cosmetic composition
GB9118979D0 (en) * 1991-09-04 1991-10-23 Unilever Plc Cosmetic composition
AU5018893A (en) * 1992-08-17 1994-03-15 Alcon Laboratories, Inc. Substituted hydrindanes for the treatment of angiogenesis-dependent diseases
US5753612A (en) * 1992-10-27 1998-05-19 Yissum Research Development Co. Of The Hebrew University Of Jerusalem Pharmaceutical composition and method for inhibiting hair growth by administration of activin or activin agonists
US5364885A (en) * 1992-11-13 1994-11-15 Ahluwalia Gurpreet S Reduction of hair growth
US5407944A (en) * 1993-02-19 1995-04-18 Goldman; Boris E. Compositions and methods for promoting hair growth
US6248751B1 (en) * 1993-05-28 2001-06-19 Gurpreet S. Ahluwalia Inhibition of hair growth
US6239170B1 (en) * 1993-05-28 2001-05-29 Gurpreet S. Ahluwalia Inhibition of hair growth
JPH07112923A (ja) * 1993-10-15 1995-05-02 Immuno Japan:Kk 新規育毛剤
US5554608A (en) * 1994-09-28 1996-09-10 Ahluwalia; Gurpreet S. Inhibition of hair growth
WO1997041844A1 (en) * 1996-05-09 1997-11-13 Alcon Laboratories, Inc. Combinations of angiostatic compounds
FR2753375B1 (fr) * 1996-09-17 1999-12-03 Oreal Utilisation dans une composition cosmetique ou pour la preparation d'un medicament d'au moins un inhibiteur de sulfotransferases

Also Published As

Publication number Publication date
ZA961600B (en) 1996-09-05
AU5300996A (en) 1996-09-18
ES2175084T3 (es) 2002-11-16
US6093748A (en) 2000-07-25
AR003411A1 (es) 1998-08-05
BR9607060A (pt) 1998-12-15
EP0812185B1 (de) 2002-07-03
EP0812185A2 (de) 1997-12-17
CA2213404C (en) 2001-09-25
CA2213404A1 (en) 1996-09-06
JP4063868B2 (ja) 2008-03-19
AU719106B2 (en) 2000-05-04
MX9706522A (es) 1997-11-29
WO1996026712A3 (en) 1996-11-21
JPH11501035A (ja) 1999-01-26
WO1996026712A2 (en) 1996-09-06
DE69622154D1 (de) 2002-08-08
DE69622154T2 (de) 2003-02-13

Similar Documents

Publication Publication Date Title
ATE219928T1 (de) Verwendung von angiogenese-suppressoren zur hemmung des haarwuchses
DE69630311D1 (de) Verminderung des haarwuchses
DE69413815D1 (de) Inhibierung des Haarwuchses
DE69617652D1 (de) Verminderung des haarwuchses
DE69427756D1 (de) Hemmung des haarwachstum
DE69726001D1 (de) Verminderung des haarwuchhses
DE69632321D1 (de) Schrittmachersystem zur verringerung des defilibrationsschwellenwertes
ATE254443T1 (de) Inhibitierung des haarwuchses
DE69310560D1 (de) Massnahmen zur Verbesserung von digitalen Filtern
DE59310137D1 (de) Verwendung von substituierten Benzimidazolen zur Bekämpfung parasitärer Protozoen
DE69715827D1 (de) Verwendung von aloe extrakt enthaltenden zahnprothesehaftmitteln
DE69822669D1 (de) Verminderung des haarwuchses
DE69720053D1 (de) Verminderung des haarwuchses
DE69825607D1 (de) Verminderung des haarwuchses
DE69934510D1 (de) Verminderung des haarwuchses
FI954541L (fi) Keratinosyyttikasvutekijän terapeuttisia käyttöjä
ATE216979T1 (de) Anwendung von amides zur kontrolle des biobewuchses
DE69533723D1 (de) Verwendung von chloridekanalblockern zur senkung des intraokulären druckes
DE69515070D1 (de) Zusammensetzung auf der Basis von alpha-Pyronen zur Induzierung und Stimulierung des Haarwachstums und/oder zur Verlangsamung des Haarausfalls und ihre Verwendung
ATE218862T1 (de) Verwendung von 1-hydroxy-2-pyridonen zur behandlung von hautinfektionen
DE69628195D1 (de) Verwendung von xyloglucanendotransglycosylase
DE69625877D1 (de) Verwendung von 5-HT1A Rezeptor-Liganden zur Behandlung des Glaukoms
DE69614264D1 (de) Behandlung von aluminiumartikeln zur erhöhung der einbrennhärtbarkeit
DE69531048D1 (de) Verwendung von steroidsulphatase-hemmern
ATE410181T1 (de) Verwendung von intereferon gamma zur behandlung von herzhypertrophie

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties